Hims & Hers Health, Inc. - HIMS STOCK NEWS

Hims & Hers Health, Inc. (NYSE: HIMS) will report its third quarter 2022 financial results after the market closes on November 7, 2022. A conference call to discuss the results will be held at 5:00 p.m. ET, accessible via U.S. dialing at (888) 510-2630 and internationally at (646) 960-0137, with conference ID 1704296. Hims & Hers is a consumer-first health platform offering treatments for various conditions, connecting patients with healthcare professionals for prescription fulfillment through a subscription model.

Hims & Hers Health, Inc. (NYSE: HIMS) has appointed Brian O’Shaughnessy as Chief Communications Officer and Josh Krueger as VP of Fulfillment Operations. O’Shaughnessy brings over two decades of experience from Google and Skype, where he led notable product communications. Krueger, formerly at Walmart and Amazon, has significant expertise in fulfillment operations. These hires aim to enhance Hims & Hers’ growth and improve customer experiences, following strong financial results with over $100 million in revenue and 100,000 new subscribers in Q2 2022.

Hims & Hers Health has launched its mobile apps on Android following a successful iOS rollout in Q1 2022. This expansion allows users to engage with the brand 3x more than before. The apps offer features such as subscription management, shipment tracking, and access to medical experts. They include innovative programs designed to improve consumer wellness. The company aims to enhance access to healthcare and wellness solutions, serving a broad range of health conditions through its platform.

Hims & Hers Health reported Q2 2022 revenue of $113.6 million, marking an 87% year-over-year increase. The company achieved over 100k net new subscriptions, totaling 817,000, an 80% increase from the previous year. Hims & Hers raised its full-year 2022 revenue guidance to $470 million to $485 million, with an adjusted EBITDA forecast of $(27) million to $(20) million. The company anticipates adjusted EBITDA profitability within the next four quarters, driven by operational efficiencies and strong platform demand.

Hims & Hers Health, Inc. will announce its second quarter 2022 financial results on August 8, 2022, at 4:15 p.m. E.T.. A conference call will follow at 5:00 p.m. E.T. Participants can join by dialing +1 (888) 510-2630 for U.S. callers or +1 (646) 960-0137 for international callers, with the conference ID #1704296. The call will also be available via a live audio webcast. Hims & Hers offers a multi-specialty telehealth platform and serves a variety of health needs, with operations in the U.S. and the U.K.

Hims & Hers Health, Inc. has launched a new line of supplements, Hers Wellness Essentials, specifically designed for women. The six products target various health concerns, including general health, mental wellness, gut health, digestive health, skin health, and libido. Available at CVS Pharmacy and other online platforms, these gluten-free, non-GMO, and vegetarian supplements utilize effective, naturally occurring ingredients. This expansion signifies Hims & Hers' commitment to offering personalized wellness options tailored to women's unique health needs.

Hims & Hers reported Q1 2022 revenue of $101.3 million, a 94% increase year-over-year, surpassing the $100 million mark for the first time. The company also achieved a net loss of $(16.3) million, improved from $(51.4) million in Q1 2021. Member subscriptions grew by 101,000 to 710,000, an 82% increase. The company raised its full year 2022 revenue guidance to between $410 million and $425 million, while maintaining Adjusted EBITDA guidance of $(30 million) to $(20 million).

Hims & Hers Health, Inc. (NYSE: HIMS) will report its Q1 2022 financial results on May 9, 2022, at 4:15 p.m. E.T., followed by a conference call at 5:00 p.m. E.T. Participants can dial +1 (888) 510-2630 for U.S. access or +1 (646) 960-0137 for international access, using conference ID #1704296. A live audio webcast will be available at investors.forhims.com, with a replay accessible for 12 months.

Hims & Hers is a telehealth platform offering diverse healthcare services and can be accessed via a mobile app and retail locations across the U.S. and the U.K.